Zhang X, Miao X, Tan W, et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer[J]. Gastroenterology, 2005, 129: 565-576.
[2]
Tang XF, Li YM, Li SX, et al. Correlation between the nucleotide polymorphisms of COX-2 and the susceptibility to gastric cancer in Hui ethnic group[J]. Shijie Huaren Xiaohua Zazhi, 2009, 17:1772-1776.
[3]
Xie X, Ma YT, Fu ZY et al. Study on the association of cyclooxygenase-2 -765g>C and prostacyclin synthase C1117A polymorphisms and the risk of myocardial infarction in Uigur population of Xinjiang, China[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2008, 29: 598-603.
[4]
Li-Li Xing, Zhen-Ning Wang, Li Jiang, et al. Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index[J]. World J Gastroenterol, 2008, 14: 1785-1789.
[5]
Willoughby DA, Moore AR, Colville Nash PR. COX-1, COX-2 and COX-3 and the future treatment of chronic inflammatory disease [J]. Lancet, 2000, 355: 646-648.
[6]
Luo C, Strauss L, Streng T, et al. Constant expression of cyclooxygenase -2 gene in the lower urinary tract and prostate of the male rats treated with estrogen [J]. Zeitschrift fur Naturforschung, 2001, 56C: 455-463.
[7]
Dannenberg AJ, Altorki NK, Boyle JO, et al. Cyclo-oxygenase2: a pharmacological target for the prevention of cancer[J]. Lancet Oncol, 2001, 2: 544-551.
[8]
Howe LR, Dannenberg AJ. A role for cyclooxygenase-2inhibitors in the prevention and treatment of cancer[J]. Semin Oncol, 2002, 29: 111-119.
[9]
Dubois RN, Shao J, Tsujii M, et al. G1delay in cells overexpressing prostaglandin endoperoxide synthase-2[J]. Cancer Res, 1996, 56: 733-737.
[10]
Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2protein in human gastric carcinoma[J]. Clin Cancer Res, 2000, 6: 519-525.
[11]
Zimmermann KC, Sarbia M, Weber AA, et al. Cyclooxygenase-2ex-pression in human esophageal carcinoma[J]. Cancer Res, 1999, 59: 198-204.
[12]
Tucker ON, Dannenberg AJ, Yang EK, et al. Cyclooxygenase-2expres-sion is up-regulated in human pancreatic cancer[J]. Cancer Res, 1999, 59: 987-990.
[13]
Koga H, Sakisaka S, Ohishi M, et al. Expression of cyclooxygenase-2in human hepatocellular carcinoma:relevance to tumor dedifferentiation[J]. Hepatol, 1999, 29: 688-696.
[14]
Pereira C, Sousa H, Ferreira P, et al. -765G>C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal Metaplasia[J]. World J Gastroenterol, 2006, 12: 5473-5478.
[15]
Papafili A, Hill MR, Brull DJ, et al. Common promoter variant in cyclooxyygenase-2 represses gene expression: evidence of role in acute-phase inflammation response[J]. Arterioscler Thromb Vasc Biol, 2002, 22: 1631-1636.
[16]
Cipollone F, Toniato E, Martinotti S, et al. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and Stroke[J]. JAMA, 2004, 291: 2221-2228.
[17]
Szczklik W, Sanak M, Seceeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma[J]. Allergy clin Immunol, 2004, 114:248-253.
[18]
Shi J, Misso NL, Duffy DL, Thompson PJ, et al. A functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian population[J]. Clin Exp Allergy, 2004, 34: 1714-1718.
[19]
Arif E, Vibhuti A, Deepak D, et al. COX2 and P53 risk-alleles coexist in COPD[J]. Clin Chim Acta, 2008, 397: 48-50.
[20]
Hamajima N, Takezaki T, Matsuo K, et al. Genotype frequencies of cyclooxygenase 2(COX-2)rare polymorphisms for Japanese with and without colorectal cancer[J]. Asian Pac J Cancer Prev, 2001, 2:57-62.
